IL17C and breast cancer: Since IL-17A, IL-17F, and IL-17C are initiators of IL-17 signal transduction, whereas IL-17E suppresses Th17 cell responses, ER downregulates IL-17 signal transduction in breast cancer by differentially regulating the expression of IL-17 cytokines.